Clinical Trials Support (Phase I - IIa)

• Drug and drug metabolite method development, validation, and sample analysis in all human matrices
• Custom immunological method development, validation, and sample analysis related to monitoring immune response to biological or protein therapies
• Preclinical study design benefits from clinical expertise
• Seamless transition from preclinical to clinical phase of drug development
• A "single" service provider that capitalizes on large company resources yet maintains the flexibility of a small organization
• Comprehensive service offering for pipeline development, i.e. building on experience from previous drug development successes/challenges and using them to expedite future products as they progress through the development process
• A platform for drug development that capitalizes on streamlined communication through infrastructure already in place between clinical and preclinical personnel
• A drug development environment where both preclinical and clinical service providers are relationship-focused, provide individualized attention, are flexible in study design and process, and understand the complexity and uncertainty in novel research